P&G Hygiene and Health Q4 profit dips 13.12 pc to Rs 42.55 cr

In 1995, he took early retirement to become a full-time writer.Shares of Procter Gamble Hygiene and Health Care Ltd on Tuesday closed at Rs 14,337.30 on BSE, down 1.78 per cent from the previous close.

FMCG products maker Procter & Gamble Hygiene and Health Care Ltd on Tuesday reported a 13.12 percent decline in Profit After Tax (PAT) at Rs 42.55 crore during the fourth quarter ended June 30, on account of rising commodity costs.

The company, which follows July-June financial year, had reported a PAT of Rs 48.98 crore in the corresponding quarter of the previous fiscal.

Its revenue from the sale of products was down 3.8 percent to Rs 755.65 crore during the quarter under review, as against Rs 785.58 crore in the corresponding quarter, Procter & Gamble Hygiene and Health Care Ltd (PGHH) said in a regulatory filing.

The company, which owns popular brands such as Vicks in healthcare and Whisper in feminine care - said the decline in profit was largely due to ''commodity cost inflation''.

''For the quarter, both feminine care and healthcare businesses continue to grow and maintain category leadership,'' said an earning statement from the FMCG company.

The company's total expense was at Rs 724.31 crore in the April-June quarter, down marginally as against Rs 725.06 crore.

For its financial year ended on June 30, 2022, PGHH's PAT was down 11.66 percent at Rs 575.75 crore. It was Rs 651.79 crore a year before.

The decline in profit was due to ''commodities inflation which was significantly countered by cost productivity and pricing in the current year,'' the company said.

However, it also added: ''Compared to the fiscal two years ago, the company's sales are up 30 percent and PAT is up 33 percent.'' However, its sales were up 6.22 percent to Rs 3,792.45 crore for the fiscal ended on June 30, 2022. It was at Rs 3,570.24 crore a year before that.

Commenting on the results PGHH Managing Director LV Vaidyanathan said the operating environment continues to be marked by unprecedented headwinds and commodity fluctuations.

''Despite these challenges, we remain resilient, agile, and committed to serving Indian consumers, delivering sequential sales growth this year,'' he said.

PGH board has also recommended a final dividend of Rs 65 per equity share for a share having a face value of Rs 10 each.

Meanwhile, in a separate filing PGHH said its board in a meeting held on Tuesday has appointed Gurcharan Das as Non-Executive Independent Director of the company, for five years, with effect from September 1, 2022.

''The said appointment is subject to the approval of the shareholders of the company,'' it said.

Das is the former CEO of Procter & Gamble India and later Managing Director, Procter & Gamble Worldwide (strategic planning). In 1995, he took early retirement to become a full-time writer.

Shares of Procter & Gamble Hygiene and Health Care Ltd on Tuesday closed at Rs 14,337.30 on BSE, down 1.78 percent from the previous close.